Oxygenation in tumors by modified hemoglobins

Journal of Surgical Oncology

Volumn 62, Issue 2, 1996, Pages 109-114

  Nozue, Mutsumi ^a,d   Lee, Intae ^b   Manning, James M ^c   Manning, Lois R ^c   Jain, Rakesh K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b Department of Anesthesiology   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

carbogen; Eppendorf 'Histograph'; modified hemoglobin; tumor oxygenation

Indexed keywords

ALDEHYDE; BENZENESULFONIC ACID DERIVATIVE; CARBOGEN; HEMOGLOBIN; MACROGOL; OXYGEN; TETRAMER;

ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CROSS LINKING; DOSE RESPONSE; HALF LIFE TIME; HEMODYNAMICS; MOUSE; NONHUMAN; OXYGEN TENSION; OXYGENATION; PRIORITY JOURNAL; TIME; TUMOR;

ANIMALS; BLOOD PRESSURE; CARBON DIOXIDE; CATTLE; CELL HYPOXIA; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROSARCOMA; GLIOMA; HALF-LIFE; HEMOGLOBINS; HUMANS; MICE; MICE, INBRED C3H; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; OXYGEN; TIME FACTORS; TUMOR CELLS, CULTURED;

EID: 0029935987     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199606)62:2<109::AID-JSO6>3.0.CO;2-C     Document Type: Article

References (24)

1. 2-histography. Int J Radiat Oncol Biol Phys 19:952-961, 1990.
2. Kennedy K, Teicher B, Rockwell S, Sartorelli A: The hypoxic tumor cell: A target for selective cancer chemotherapy. Biochem Pharmacol 29:1-8, 1980.
3. Teicher BA, Rose CM: Effect of dose and scheduling on growth delay of the Lewis lung carcinoma produced by the perfluorochemical emulsion, Fluosol-DA. Int J Radiat Oncol Biol Phys 12:1311-1313, 1986.
4. 2 on the antitumor activity and pulmonary toxicity of bleomycin. Cancer Chemother Pharmacol 18:213-218, 1986.
5. Gatenby R, Kessler H, Rosenblum J, et al.: Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy. Int J Radiat Oncol Biol Phys 14:831-838, 1988.
6. 2 predicts survival in advanced cancer of the uterine cervix. Radiother Oncol 26:45-50, 1993.
7. Teicher BA, Schwartz GN, Alvarez-Sotomayor E, et al.: Oxygenation of tumors by a hemoglobin solution. J Cancer Res Clin Oncol 120:85-90, 1993.
8. Teicher B, Herman T, Hopkins R, Menon K: Effect of oxygen level on the enhancement of tumor response to radiation by perfluorochemical emulsions or a bovine hemoglobin preparation. Int J Radiat Oncol Biol Phys 21:969-974, 1991.
9. Manning LR, Morgan S, Beavis RC, et al.: Preparation, properties, and plasma retention of human hemoglobin derivatives: Comparison of uncrosslinked carboxymethylated hemoglobin with crosslinked tetrameric hemoglobin. Proc Natl Acad Sci USA 88:3329-3333, 1991.
10. Manning JM: Design of chemically modified and recombinant hemoglobins as potential red cell substitutes. In Winslow RM, Vandegriff KD, Intaglietta M (eds): "Blood Substitutes: Physiological Basis of Efficacy." Boston: Birkhäuser, 1995, p 76-89.
11. Manning LR, Manning JM: Influence of ligation state and concentration of hemoglobin A on its cross-linking by glycoaldehyde: Functional properties of cross-linked, carboxymethylated hemoglobin. Biochemistry 27:6640-6644, 1988.
12. Nho K, Zalipsky S, Abuchowski A, Davis FF: PEG-modified hemoglobin as an oxygen carrier. In Harris JM (eds): "Poly(Ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications." New York: Plenum Press, 1992, p 171-182.
13. Tsai AG, Kerger H, Intaglietta M: Microcirculatory consequences of blood substitution with aa-hemoglobin. In Winslow RM, Vandegriff KD and Intaglietta M (eds): "Blood Substitutes: Physiological Basis of Efficacy." Boston: Birkhäuser, 1995, p 155-174.
14. GlogarD, Kloner R, Muller J, et al.: Fluorocarbons reduce myocardial ischemic damage after coronary occlusion. Science 211: 1439-1441, 1981.
15. Lee I, Levitt S, Song C: Radiosensitization of murine tumors by Fluosol-DA 20%. Radiat Res 122:275-279, 1990.
16. Lee I, Cunningham W, Levitt S: Improvement in RBC flux, acidosis and oxygenation in tumour microregions by Fluosol-DA 20%. Int J Radiat Biol 60:695-705, 1991.
17. Lee I, Demhartner TJ, Boucher Y, et al.: Effect of hemodilution and resuscitation on tumor interstitial fluid pressure, blood flow, and oxygenation. Microvasc Res 48:1-12, 1994.
18. Jain RK: Determinants of tumor blood flow: A review. Cancer Res 48:2641-2658, 1988.
19. 2 availability during hemodilution. Adv Exp Med Biol 180:281-291, 1984.
20. Siemann DW: Keynote address: Tissue oxygen manipulation and tumor blood flow. Int J Radiat Oncol Biol Phys 22:393-395, 1992.
21. Siemann D, Macler L: Tumor radiosensitization through reductions in hemoglobin affinity. Int J Radiat Oncol Biol Phys 12:1295-1297, 1986.
22. Hirst DG, Wood PJ: The influence of haemoglobin affinity for oxygen on tumour radiosensitivity. Br J Cancer 55:487-491, 1987.
23. Yuan F, Leunig M, Berk DA, Jain RK: Microvascular permeability of albumin, vascular surface area, and vascular volume measured in human adenocarcinoma LS174T Using dorsal chamber in SCID mice. Microvasc Res 45:269-289, 1993.
24. Dvorak H, Nagy J, Dvorak J, Dvorak A: Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 133:95-109, 1988.